EZC Pak Immune Support Update | Shark Tank Season 11
Antibiotic resistance is a problem that many doctors across the US are facing every day. So why not make people healthier overall? That was the idea behind Dr. Sarath Malepati’s EZC Pak immune support supplements. A rocky
Shark Tank EZC Pak Update
- Entrepreneur: Dr. Sarath Malepati
- Business: Immune support alternative to antibiotics
- Ask: $125,000 for 5% equity
- Result: $125,000 for 5% and $1/unit in royalties until $450,00
- Shark: Kevin O’Leary
Dr. Sarath Malepati was tired of seeing patients go through unnecessary amputations because they’d become resistant to antibiotics. During a pitch headed by cartoon ‘bugs,’ he explained that consumer-driven medical practices were at fault for one of the largest issues with antibiotics.
EZC Pak combined echinacea, zinc, and vitamin C to help strengthen the user’s immune system. This protected against viruses, which antibiotics won’t kill, but were often misprescribed to treat.
It wasn’t the best pitch ever, something that the sharks acknowledge. Mark Cuban even interrupted him as his pitch winded down and stated that there’s no way this product worked, and he didn’t believe or support the product claims. Mark Cuban sometimes gets brutal with entrepreneurs, and this is one of those times.
Despite Mark’s comments, Dr. Malepati kept trying to fix his pitch, speaking over Lori in the process. She was upset by what she perceived as chauvinism, so she went out after giving Dr. Malepati another thrashing. Robert Herjavec followed, simply stating that the product wasn’t for him. Guest shark Daniel Lubetzky thought the doctor would be too much of a know-it-all, so he dropped out as well.
It was up to Kevin O’Leary to give this entrepreneur the deal he was seeking. After a discussion about the numbers, he made an offer, $125,000 in exchange for 5% equity and a perpetual $0.60 royalty per unit. Dr. Malepati asked what level of involvement he can expect from Kevin, which won him no favors.
After some haggling, they ended up with a different deal. Kevin O’Leary would give him $125,000 for 5% equity, plus $1 per unit in royalties until they reach $450,000. Was this a worthwhile investment? Find out in our EZC Pak update.
EZC Pak was originally created to combat issues caused by viruses. In our EZC Pak update, we found that the company has grown by leaps and bounds during the pandemic. Now, you can find EZC Pak in CVS, HyVee, Walmart, and a host of other grocery store chains. It’s also available on Amazon. Sources have reported an 850% online sales boost over the last year, and 300% in sales overall. Revenue for the company hasn’t been reported, but it’s safe to say that Dr. Malepati isn’t regretting his decision to leave his day job.
You can find the other company updates from Season 11 Episode 6 here:
Don’t forget to take a look at our Season 11 products page! We’ve got more company updates from
